Investment Rating - The report maintains a "Buy" rating for the company [2][5][10] Core Views - The company is expected to achieve significant revenue growth, with projected earnings per share (EPS) for 2025-2027 at 2.71, 3.42, and 4.19 RMB respectively, reflecting an upward adjustment from previous estimates [2][10] - The target price is set at 97.72 HKD, based on a 33x price-to-earnings (PE) ratio for 2025 [2][10] - The company has demonstrated strong performance in the first half of the year, with revenue growth driven by its main brand, Han Shu, and the rapid expansion of its infant brand, Yi Ye [9][10] Financial Information Summary - Revenue (in million RMB) is projected to grow from 4,191 in 2023 to 12,350 in 2027, with year-on-year growth rates of 56.6%, 62.1%, 24.7%, 22.3%, and 19.2% respectively [4][12] - Operating profit is expected to increase from 414 million RMB in 2023 to 1,739 million RMB in 2027, with significant growth rates of 308.5% in 2023 and 67.8% in 2024 [4][12] - Net profit attributable to the parent company is forecasted to rise from 461 million RMB in 2023 to 1,669 million RMB in 2027, with growth rates of 213.5% in 2023 and 69.4% in 2024 [4][12] - The gross margin is projected to improve from 72.1% in 2023 to 76.7% in 2027, while the net margin is expected to increase from 11.0% to 13.5% over the same period [4][12] Market Performance - The company's stock has shown strong absolute performance, with a 165.8% increase over the past 12 months [6] - The stock price as of August 6, 2025, was 87.75 HKD, with a 52-week high of 90.9 HKD and a low of 28.84 HKD [5]

Investment Rating - The investment rating for the company is "Cautious Accumulate" [1]. Core Views - The company's operational efficiency continues to improve in H1 2025, with promising growth potential for future store expansions [2]. - The report maintains an "Accumulate" rating and raises the forecast for the company's net profit attributable to shareholders for 2025-2027 to 4.20 billion, 5.05 billion, and 6.17 billion RMB respectively [11]. Financial Summary - Total revenue for 2023 is reported at 6.094 billion RMB, with projections of 6.470 billion for 2024, 7.451 billion for 2025, 8.309 billion for 2026, and 9.471 billion for 2027, reflecting a growth rate of -15%, 6%, 15%, 12%, and 14% respectively [5]. - Gross profit for 2023 is 1.351 billion RMB, with estimates of 1.417 billion for 2024, 1.654 billion for 2025, 1.845 billion for 2026, and 2.103 billion for 2027 [5]. - The net profit attributable to shareholders is projected to be 240 million RMB for 2023, decreasing to 231 million in 2024, then increasing significantly to 420 million in 2025, 505 million in 2026, and 617 million in 2027, with growth rates of 4%, -4%, 82%, 20%, and 22% respectively [5]. - The company plans to distribute an interim dividend of 0.0716 RMB per share, totaling 1.90 billion RMB, with a dividend payout ratio of 100% [11]. Operational Highlights - In H1 2025, the company achieved a revenue of 32.40 billion RMB, a year-on-year increase of 21.6%, with a gross profit of 7.17 billion RMB, up 17.8% [11]. - The number of stores reached 10,400, an 8% increase year-on-year, with a net addition of 250 stores in H1 2025 [11]. - The company introduced 175 new SKUs in the hot pot and barbecue categories, enhancing its product offerings [11]. Market Positioning - The company aims to strengthen its supply chain and expand into lower-tier markets, with plans to explore overseas markets [11]. - The report suggests a target price of 4.24 HKD for 2025, based on a PE ratio of 26x, which is above the industry average [11].

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Views - The company has a positive outlook for its annual operational goals, driven by the growth of innovative business trends despite a decline in overall revenue [2][6] - The company is focusing on optimizing its business structure, with significant improvements in operational quality and a release of cost pressures expected in the second half of the year [2][6] Revenue and Profit Analysis - In the first half of 2025, the company achieved revenue of 2.598 billion yuan, a year-on-year decrease of 13.2%, and a net profit attributable to shareholders of -198 million yuan, with losses widening compared to the previous year [1][2] - The ICT support business saw revenue of 2.118 billion yuan, down 14.7% year-on-year, primarily due to a decline in demand from traditional operator businesses [6] - The digital operation business generated revenue of 408 million yuan, down 8.8%, but non-telecom sector orders grew by 18.2% year-on-year, indicating strong growth potential [6] - The AI large model application and delivery business experienced explosive growth, with revenue of 26 million yuan and new orders of 70 million yuan [6] Margin and Cash Flow - The gross margin for the first half of 2025 was 30.1%, an increase of 5.4 percentage points year-on-year, attributed to cost-saving strategies and improved project quality [6] - The company reported a net cash outflow from operating activities of 594 million yuan, showing significant improvement compared to the previous year's outflow of 919 million yuan [6] Future Outlook - The company expects its three major growth engines to accelerate in the second half of 2025, with a narrowing decline in ICT support business revenue and overall profit expected to outperform the previous year [6] - Revenue forecasts for 2025-2027 are projected at 6.915 billion, 7.461 billion, and 8.269 billion yuan, with net profits of 571 million, 674 million, and 777 million yuan respectively [6][8]

Investment Rating - The report maintains a "Buy" rating for the company [3][6]. Core Views - The company demonstrated robust performance with revenue and profit exceeding expectations, achieving a revenue of 17.087 billion RMB in H1 2025, a year-on-year increase of 10.6%, and a net profit of 1.287 billion RMB, up 33.2% year-on-year [1][3]. - The food segment showed strong growth, with revenue of 5.382 billion RMB in H1 2025, a year-on-year increase of 8.8%, and a profit of 190 million RMB, up 32.1% year-on-year [1]. - The beverage segment also performed well, generating revenue of 10.788 billion RMB in H1 2025, a year-on-year increase of 7.6%, with notable growth in tea beverages [2]. Summary by Sections Food Business - The food division's revenue reached 5.382 billion RMB in H1 2025, reflecting an 8.8% increase year-on-year, contributing 31.5% to total revenue [1]. - Key products like "Soup Master" and "Unified Old Pickled Cabbage Beef Noodles" showed steady growth, with "Eggplant King" achieving double-digit growth and "Full Han Feast" seeing high double-digit growth [1]. Beverage Business - The beverage segment generated 10.788 billion RMB in H1 2025, a 7.6% year-on-year increase, accounting for 63.1% of total revenue [2]. - Revenue from tea beverages, juice, and milk tea reached 5.068 billion, 1.821 billion, and 3.398 billion RMB respectively, with year-on-year growth rates of 9.1%, 1.7%, and 3.5% [2]. - The beverage division's profit was 1.544 billion RMB, up 25.4% year-on-year [2]. Financial Performance - The company achieved a gross margin of 34.3% in H1 2025, an increase of 0.5 percentage points year-on-year, driven by sales growth and a decrease in raw material prices [2]. - The net profit margin improved significantly to 7.5%, up 1.3 percentage points year-on-year, due to revenue growth, improved gross margin, and reduced expense ratios [2]. Investment Outlook - The company is expected to maintain steady performance with a projected net profit growth of 24.3%, 13.4%, and 11.7% for 2025, 2026, and 2027, reaching 2.299 billion, 2.608 billion, and 2.914 billion RMB respectively [3]. - The strong demand for instant noodles and beverages, along with effective market expansion strategies, positions the company well for future growth [3].

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is facing significant revenue pressure in the first half of 2025, with expected revenue decline of 38.3% to 41.9% year-on-year, and net profit decline of 23% to 24% [7] - Despite the challenges, the company is actively managing its operations, maintaining a stable profit margin of 24% to 25% in the first half of 2025, indicating strong cost and expense control capabilities [7] - The company is focusing on clearing inventory and optimizing its distribution channels, with expectations for a more controlled revenue decline in the second half of 2025 as market conditions improve [7] - The company is adapting to industry pressures by shifting its customer base and product offerings, including the introduction of new products at competitive price points [7] Financial Forecasts - Total revenue is projected to be 7,060 million in 2023, with a slight increase to 7,067 million in 2024, followed by a significant drop to 5,026 million in 2025 [1] - The net profit for 2023 is estimated at 2,327 million, decreasing to 1,324 million in 2024, and further to 1,158 million in 2025 [1] - Non-IFRS net profit is expected to be 1,623 million in 2023, with a decline to 1,676 million in 2024, and a drop to 1,233 million in 2025 [1] - The report adjusts the non-IFRS net profit forecasts for 2025 to 12.3 billion, 13.7 billion, and 16.8 billion for 2025, 2026, and 2027 respectively [7] Market Data - The closing price of the stock is 7.38 HKD, with a market capitalization of approximately 22,749.82 million HKD [5] - The company has a price-to-earnings (P/E) ratio of 9.77 for the current price and latest diluted earnings per share (EPS) of 0.69 [1] - The company’s book value per share is 4.12, with a debt-to-asset ratio of 28.84% [6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][5] Core Views - The company is expected to achieve accelerated performance growth in 2026 due to the completion of overseas capacity relocation by the end of 2025, which will fully cover shipments to the U.S. market [5][7] - The company has adjusted its net profit forecasts for 2025-2027 from $1.35 billion, $1.63 billion, and $1.94 billion to $1.29 billion, $1.56 billion, and $1.84 billion, reflecting year-on-year growth rates of 14.7%, 21.4%, and 17.9% respectively [5][6] - The company's core brands, Milwaukee and RYOBI, continue to show strong growth, with Milwaukee achieving a year-on-year increase of 11.9% and RYOBI 8.7% in the first half of 2025 [6][7] Financial Summary and Valuation Metrics - Revenue for 2025 is projected at $15.52 billion, with a year-on-year growth of 6.1% [8] - Net profit for 2025 is estimated at $1.29 billion, reflecting a year-on-year increase of 14.7% [8] - The gross margin is expected to improve to 40.6% in 2025, while the net margin is projected at 8.3% [8] - The diluted EPS is forecasted to be $0.7 for 2025, with a P/E ratio of 17.3 times [8]

证券研究报告 港股通 小米集团-W (1810 HK) 2Q25 业绩预览：关注"反内卷"的影响 2025 年 8 月 07 日│中国香港 消费电子 我们预计小米 2Q25 收入同比增长 29%，毛利率环比下降 0.3pp，归属于母 公司净利润同比增长 56%。其中包含手机，IoT 和互联网业务在内的原有主 业收入同比增长 14%，汽车业务实现 204 亿收入，环比增长 10%。展望全 年：1）汽车。6 月 YU7 发布后大定数据亮眼，产能仍然是收入的主要瓶颈。 此外，近期汽车行业"反内卷"趋势下，看好汽车行业高质量发展以及行业 参与者长期盈利能力提升；2）手机。海外存储原厂供应减少，存储价格呈 现上涨趋势，建议关注存储价格上涨对手机毛利率的影响。给予公司目标价 67.8 港币（前值：71.2 港币），包含非汽车（44.3 港币），汽车（23.5 港 币）。维持"买入"。 汽车业务：看好"反内卷"长期提升汽车业务盈利能力 我们预计 2Q25 小米汽车出货约 8.1 万台，ASP 环比有所提升，实现收入 204 亿人民币，环比提升 10%，随着出货量爬坡，我们预计毛利率环比提 升 0.5pp 至 23.7%。展 ...

Investment Rating - The report maintains a "Buy" rating for the company [4] Core Views - The company has exceeded expectations in its first half performance for 2025, with projected revenue of 40.9 to 41.1 billion yuan, representing a year-on-year growth of 16.8% to 17.3%, and a net profit of 5.4 to 5.6 billion yuan, indicating a growth of 30.9% to 35.8% [1][2] - The strong performance is attributed to the continuous growth of the main brand, Han Shu, and significant contributions from smaller brands like Newpage [2] - The company has optimized its brand strategy, particularly for Han Shu, which accounted for 82.3% of revenue in 2024, enhancing its multi-category layout and overall competitiveness [2] - During the major e-commerce promotion event in June 2025, Han Shu maintained its leading position in sales across multiple platforms, with significant year-on-year growth in sales on platforms like Tmall and JD [2][3] Summary by Sections Financial Performance - The company has adjusted its profit forecasts upwards for 2025 to 2027, with expected net profits of 11.6 billion, 14.6 billion, and 17.6 billion yuan respectively, reflecting increases of 10%, 6%, and 1% from previous estimates [4] - The projected price-to-earnings (P/E) ratio for 2025 is 27 times, indicating a positive outlook on the company's multi-brand development and net profit margin trends [4] Revenue and Profit Growth - The company anticipates a revenue growth rate of 23.6% for 2025, with net profit growth expected at 48.4% [5] - The earnings per share (EPS) is projected to reach 2.91 yuan in 2025, with a return on equity (ROE) of 45.7% [5][12] Market Position - The company has established a strong market presence, particularly in the beauty and skincare sectors, with Han Shu leading in sales rankings on platforms like Douyin and Tmall [2][3] - The report highlights the company's successful transition from a single-brand focus to a multi-brand, all-channel strategy, enhancing its competitive edge in the market [9]

Investment Rating - The report assigns a "Buy" rating to the company [10]. Core Insights - Yuehai Investment is a Guangdong state-owned enterprise with a strong portfolio in water supply to Hong Kong, holding a 30-year concession for the Dongshen Water Supply Project, which accounts for 70%-80% of local freshwater usage. The company is expected to enter a stable dividend phase by 2025, with an estimated dividend yield of 6.77% [3][6]. Summary by Sections Company Overview - Yuehai Investment is primarily focused on water resources, with the Guangdong provincial government holding a 58.27% stake. The company operates five main business segments, with the water resources segment contributing 81% to the overall pre-tax profit. The Dongshen Water Supply Project is the core asset, providing stable cash flow [6][16]. Water Resources - The Dongshen Water Supply Project has a supply capacity of 2.423 billion cubic meters annually, supplying 70%-80% of Hong Kong's freshwater and over 50% of Shenzhen's water. The project is expected to generate 39% of its total supply to Hong Kong in 2024, contributing 81% to the project's total revenue [7][36]. Other Water Projects - Other water resource projects have entered a stable operational phase, with a design capacity of 5.895 billion tons/year for water supply and 1.221 billion tons/year for sewage treatment. Revenue from construction has declined significantly, indicating a shift to stable operations [8][30]. Other Business Segments - The performance of other business segments has stabilized after the removal of factors causing volatility. The contributions to pre-tax profit from various segments are 81% from water resources, 10% from property investment, and smaller percentages from other sectors [9][23]. Financial Analysis & Profit Forecast - The company is projected to achieve a sustainable net profit of HKD 4.1 billion in 2024, with a debt ratio of 30.9% by the end of 2024. The dividend payout ratio is expected to remain at 65% for 2023-2024, with forecasted net profits of HKD 4.54 billion, HKD 4.75 billion, and HKD 4.83 billion for 2025-2027, respectively [10][28].

Investment Rating - The report maintains a "Buy" rating for the company, anticipating a price increase of over 15% in the next 6-12 months [5]. Core Insights - The company reported total revenue of $1.3 billion in Q2 2025, a year-on-year increase of 42%, and achieved a GAAP net profit of $94.32 million, marking a return to profitability [2]. - The core product, Zebutinib, has rapidly gained market share, becoming the leader in the U.S. BTKi market with Q2 sales of $950 million, up 49% year-on-year and 20% quarter-on-quarter [3]. - The company has raised its full-year guidance for 2025, projecting total revenue between $5 billion and $5.3 billion, with GAAP operating expenses of $4.1 billion to $4.4 billion and a gross margin in the mid-high 80% range [3]. - The R&D pipeline is expected to see significant catalysts in the second half of 2025, including key clinical trial milestones and regulatory approvals [4]. - The company has revised its net profit forecasts for 2025-2027 to $306 million, $763 million, and $1.186 billion, respectively, reflecting a continuous improvement in profitability [5]. Summary by Sections Performance Review - In Q2 2025, the company achieved total revenue of $1.3 billion, a 42% increase year-on-year, and a GAAP net profit of $94.32 million, indicating a turnaround from previous losses [2]. Operational Analysis - Zebutinib's sales reached $950 million in Q2 2025, with a 49% year-on-year growth and a 20% quarter-on-quarter increase, establishing it as the leading product in the U.S. BTKi market [3]. - The company also reported sales of $194 million for Tislelizumab, growing 22% year-on-year and 13% quarter-on-quarter [3]. R&D Pipeline - The company anticipates several key R&D milestones in H2 2025, including clinical trial analyses and regulatory submissions for various products [4]. Financial Forecasts - The company has updated its revenue guidance for 2025 to between $5 billion and $5.3 billion, with a projected GAAP net profit for the year [3][5]. - The net profit forecasts for 2025, 2026, and 2027 are set at $306 million, $763 million, and $1.186 billion, respectively, indicating strong growth potential [5].